MedTrace Logo

Idylla EGFR Lung Trial

NCT04962191 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-07-14

No results posted yet for this study

Summary

This retrospective, observational study will compare the results of a BioCartis' EGFR mutation test on the Idylla platform with test results from SoC pathology results from tissue biopsies in the same setting. A comparable rapid testing platform for EGFR may serve as a more accessible means to diagnose, and overall, more patients treated successfully with targeted therapies. Up to 150 samples will be tested and compared with existing results.

Conditions

Interventions

DIAGNOSTIC_TEST

Idylla EGFR Mutation Test

This diagnostic test is performed on the BioCartis Idylla System for qualitative detection of exon mutations.

Sponsors & Collaborators

  • Anthony Magliocco

    lead INDUSTRY

Principal Investigators

  • Anthony Magliocco, MD · CEO and Founder

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2022-12-31
Completion
2023-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962191 on ClinicalTrials.gov